We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

TBK1 Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant full-length human TBK1 was expressed by baculovirus in Sf9 cells using an N-terminal GST tag. TBK1, also known as NAK or NFkB-activating kinase, is an upstream protein kinase that can phosphorylate and activate the IkB kinases. Activation of IkB kinases allows the phosphorylation of IkB protein, which is then degraded via the ubiquitination pathway. This mechanism allows the activation of the NFkB transcriptional complex. TBK1 is a specific upstream regulator of IkB kinases and also can interact with the IkB protein TANK. TBK1 is a component of the virus-activated kinase ...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for US customers only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

TBK1 Kinase Enzyme System

Close Window

TBK1 Kinase Enzyme System

 Components

10μg
- V3991 $ 406.00 Add to cart

TBK1 Kinase Enzyme System

Close Window

TBK1 Kinase Enzyme System

 Components

1mg
- V3992 $ 5,990.00 Add to cart

ADP-Glo™ Kinase Assay + TBK1 Kinase Enzyme System

Close Window

ADP-Glo™ Kinase Assay + TBK1 Kinase Enzyme System

 Components

  • TBK1 Kinase Enzyme System

    V39911 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V8291 $ 808.00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V3991, V3992, V8291 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V8291 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V8291 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V8291 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V8291 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V8291 U.S. Pat. No. 8,183,007 and other patents pending.

V8291 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V8291 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.